Share Price and Basic Stock Data
Last Updated: February 12, 2026, 10:08 pm
| PEG Ratio | 245.48 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Croissance Ltd operates in the construction, contracting, and engineering sector, currently priced at ₹3.44 with a market capitalization of ₹23.6 Cr. The company has experienced significant fluctuations in its revenue, with sales recorded at ₹2.60 Cr for the fiscal year ending March 2023, a notable improvement from just ₹0.20 Cr in March 2022. However, sales have dramatically declined in subsequent quarters, with only ₹0.06 Cr reported for December 2023 and an anticipated continuation of zero revenue through the first half of FY2025. This sharp downturn raises concerns about the company’s capacity to sustain its operations and generate consistent revenue streams. The operating profit margin (OPM) for March 2023 stood at 22.69%, but projections for FY2025 show a negative margin of -50.00%, indicating potential inefficiencies. Overall, while the revenue for March 2023 marked a recovery from previous years, the latest trends suggest troubling volatility that could impact future business stability.
Profitability and Efficiency Metrics
Croissance Ltd’s profitability metrics reflect substantial challenges, with a reported net profit of ₹0.49 Cr for the fiscal year ending March 2023, down from ₹0.13 Cr in March 2022. The company recorded a net profit margin of 18.79% in March 2023, which is commendable compared to historical performance but has since deteriorated, with projections indicating a net profit of zero for FY2025. The return on equity (ROE) stands at a concerning 0.00%, while the return on capital employed (ROCE) is at a meager 0.13%, suggesting that the company is struggling to generate returns from its capital base. The cash conversion cycle (CCC) has drastically increased to 13,906.50 days for March 2025, raising red flags regarding operational efficiency and liquidity management. These profitability and efficiency issues highlight the urgent need for strategic interventions to enhance operational performance and restore investor confidence.
Balance Sheet Strength and Financial Ratios
Croissance Ltd’s balance sheet reveals a cautious financial position, with total assets registered at ₹15.20 Cr as of March 2025 and no borrowings, reflecting a debt-free status that can be viewed as a strength. The company’s reserves are reported at ₹1.02 Cr, indicating a modest buffer for operational needs. However, the current ratio has declined to 0.76, below the ideal threshold of 1, suggesting potential liquidity issues. Additionally, the interest coverage ratio (ICR) is reasonably healthy at 6.61x, which indicates that the company can comfortably cover its interest obligations, although it has no debt currently. The price-to-book value (P/BV) ratio stands at 2.14x, which is relatively high compared to typical sector ranges. This elevated valuation, coupled with declining profitability metrics, may deter potential investors, raising concerns about the sustainability of the company’s financial health moving forward.
Shareholding Pattern and Investor Confidence
The shareholding structure of Croissance Ltd shows a significant promoter holding of 59.79%, indicating strong control from the founding stakeholders. The public shareholding stands at 40.22%, with a total of 12,489 shareholders reported. This distribution suggests a relatively broad base of retail investors, which could be advantageous for liquidity. However, the increasing number of shareholders from 1,604 in December 2022 to 12,489 by September 2025 indicates growing interest, yet investor confidence may wane given the company’s deteriorating financial performance in the recent quarters. The absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) could reflect a cautious stance among larger investors, potentially signaling concerns regarding the company’s future prospects. The lack of dividend payouts over the years further highlights a retention strategy, likely aimed at bolstering reserves in light of operational challenges.
Outlook, Risks, and Final Insight
The outlook for Croissance Ltd is tenuous, characterized by significant risks stemming from declining revenues and profitability. The company’s inability to generate consistent sales, coupled with a rising cash conversion cycle, could severely impact operational liquidity and sustainability. If the current trend of zero revenue persists, the company may face solvency issues that could threaten its long-term viability. Conversely, if Croissance can effectively restructure its operations and regain market demand, there is potential for recovery and growth. The company’s strong promoter backing and debt-free status provide a foundation for strategic pivots. However, the need for immediate corrective actions is critical to restore investor confidence and improve financial performance. In this volatile environment, stakeholders must closely monitor the company’s strategic initiatives to navigate these challenges successfully.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Engineering and Projects Ltd | 51.4 Cr. | 33.2 | 49.9/22.5 | 2.94 | 39.4 | 0.00 % | 20.5 % | 25.9 % | 10.0 |
| Modis Navnirman Ltd | 642 Cr. | 329 | 409/220 | 78.3 | 46.5 | 0.00 % | 12.9 % | 9.88 % | 10.0 |
| Modulex Construction Technologies Ltd | 137 Cr. | 19.3 | 30.4/18.0 | 44.7 | 0.00 % | 2.51 % | 1.54 % | 10.0 | |
| MPDL Ltd | 31.2 Cr. | 42.1 | 60.6/32.1 | 127 | 0.00 % | 2.87 % | 4.16 % | 10.0 | |
| IITL Projects Ltd | 26.0 Cr. | 52.0 | 77.9/44.6 | 18.8 | 2.12 | 0.00 % | 16.6 % | % | 10.0 |
| Industry Average | 17,461.98 Cr | 227.31 | 40.17 | 134.31 | 0.17% | 16.34% | 21.32% | 21.29 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.69 | 1.77 | 0.40 | 0.16 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.56 | 1.29 | 0.41 | 0.08 | 0.03 | 0.06 | 0.09 | 0.29 | 0.20 | -0.43 | 0.12 | 0.18 | 0.18 |
| Operating Profit | 0.13 | 0.48 | -0.01 | 0.08 | 0.03 | -0.06 | -0.09 | -0.29 | -0.20 | 0.43 | -0.12 | -0.18 | -0.18 |
| OPM % | 18.84% | 27.12% | -2.50% | 50.00% | 50.00% | ||||||||
| Other Income | 0.03 | 0.03 | 0.04 | 0.00 | 0.00 | 0.01 | 0.10 | 0.13 | -0.07 | 0.00 | 0.13 | 0.20 | 0.20 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.16 | 0.51 | 0.03 | 0.08 | 0.03 | -0.05 | 0.01 | -0.16 | -0.27 | 0.43 | 0.01 | 0.02 | 0.02 |
| Tax % | 0.00% | 43.14% | 33.33% | 0.00% | 0.00% | 40.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | 0.16 | 0.29 | 0.02 | 0.08 | 0.03 | -0.07 | 0.01 | -0.16 | -0.27 | 0.42 | 0.01 | 0.02 | 0.02 |
| EPS in Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
Last Updated: January 8, 2026, 10:02 pm
Below is a detailed analysis of the quarterly data for Croissance Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00 Cr..
- For Expenses, as of Dec 2025, the value is 0.18 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.18 Cr..
- For Operating Profit, as of Dec 2025, the value is -0.18 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded -0.18 Cr..
- For OPM %, as of Dec 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00%.
- For Other Income, as of Dec 2025, the value is 0.20 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.20 Cr..
- For Interest, as of Dec 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00 Cr..
- For Depreciation, as of Dec 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.02 Cr..
- For Tax %, as of Dec 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00%.
- For Net Profit, as of Dec 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.02 Cr..
- For EPS in Rs, as of Dec 2025, the value is 0.00. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:54 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.61 | 0.28 | 0.24 | 0.20 | 0.14 | 0.40 | 0.21 | 0.06 | 0.20 | 2.60 | 0.66 | 0.10 | 0.00 |
| Expenses | 2.52 | 0.19 | 0.18 | 0.15 | 0.13 | 0.31 | 0.16 | 0.03 | 0.15 | 2.01 | 0.58 | 0.15 | 0.07 |
| Operating Profit | 0.09 | 0.09 | 0.06 | 0.05 | 0.01 | 0.09 | 0.05 | 0.03 | 0.05 | 0.59 | 0.08 | -0.05 | -0.07 |
| OPM % | 3.45% | 32.14% | 25.00% | 25.00% | 7.14% | 22.50% | 23.81% | 50.00% | 25.00% | 22.69% | 12.12% | -50.00% | |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.12 | 0.01 | 0.06 | 0.26 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.09 | 0.09 | 0.06 | 0.05 | 0.01 | 0.09 | 0.05 | 0.03 | 0.19 | 0.71 | 0.09 | 0.01 | 0.19 |
| Tax % | 33.33% | 33.33% | 50.00% | 40.00% | 0.00% | 22.22% | 20.00% | 33.33% | 31.58% | 30.99% | 22.22% | 100.00% | |
| Net Profit | 0.06 | 0.06 | 0.04 | 0.03 | 0.01 | 0.06 | 0.03 | 0.02 | 0.13 | 0.49 | 0.07 | 0.00 | 0.18 |
| EPS in Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | -33.33% | -25.00% | -66.67% | 500.00% | -50.00% | -33.33% | 550.00% | 276.92% | -85.71% | -100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -33.33% | 8.33% | -41.67% | 566.67% | -550.00% | 16.67% | 583.33% | -273.08% | -362.64% | -14.29% |
Croissance Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -10% |
| 5 Years: | -14% |
| 3 Years: | -21% |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -19% |
| 5 Years: | -10% |
| 3 Years: | -26% |
| 1 Year: | -38% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 3:06 pm
Balance Sheet
Last Updated: December 4, 2025, 2:41 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 |
| Reserves | -6.22 | 0.09 | 0.13 | 0.16 | 0.17 | 0.24 | 0.27 | 0.29 | 0.43 | 0.92 | 1.00 | 0.99 | 1.02 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.41 | 0.49 | 0.49 | 0.04 | 0.00 | 0.00 |
| Other Liabilities | 0.09 | 0.13 | 0.15 | 0.17 | 0.20 | 0.22 | 0.40 | 0.40 | 0.45 | 2.36 | 1.36 | 7.36 | 7.37 |
| Total Liabilities | 0.72 | 7.07 | 7.13 | 7.18 | 7.22 | 7.31 | 7.52 | 7.95 | 8.22 | 10.62 | 9.25 | 15.20 | 15.24 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.72 | 7.07 | 7.13 | 7.18 | 7.22 | 7.31 | 7.52 | 7.95 | 8.22 | 10.62 | 9.25 | 15.20 | 15.24 |
| Total Assets | 0.72 | 7.07 | 7.13 | 7.18 | 7.22 | 7.31 | 7.52 | 7.95 | 8.22 | 10.62 | 9.25 | 15.20 | 15.24 |
Below is a detailed analysis of the balance sheet data for Croissance Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 6.85 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.85 Cr..
- For Reserves, as of Sep 2025, the value is 1.02 Cr.. The value appears strong and on an upward trend. It has increased from 0.99 Cr. (Mar 2025) to 1.02 Cr., marking an increase of 0.03 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 7.37 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.36 Cr. (Mar 2025) to 7.37 Cr., marking an increase of 0.01 Cr..
- For Total Liabilities, as of Sep 2025, the value is 15.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.20 Cr. (Mar 2025) to 15.24 Cr., marking an increase of 0.04 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 15.24 Cr.. The value appears strong and on an upward trend. It has increased from 15.20 Cr. (Mar 2025) to 15.24 Cr., marking an increase of 0.04 Cr..
- For Total Assets, as of Sep 2025, the value is 15.24 Cr.. The value appears strong and on an upward trend. It has increased from 15.20 Cr. (Mar 2025) to 15.24 Cr., marking an increase of 0.04 Cr..
Notably, the Reserves (1.02 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.09 | 0.09 | 0.06 | 0.05 | 0.01 | 0.09 | 0.05 | -0.38 | -0.44 | 0.10 | 0.04 | -0.05 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 92.30 | 990.71 | 1,262.29 | 1,587.75 | 2,372.50 | 921.62 | 1,998.81 | 8,881.67 | 1,679.00 | 473.10 | 2,107.05 | 13,906.50 |
| Inventory Days | 0.00 | 0.00 | 0.00 | |||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 92.30 | 990.71 | 1,262.29 | 1,587.75 | 2,372.50 | 921.62 | 1,998.81 | 8,881.67 | 1,679.00 | 473.10 | 2,107.05 | 13,906.50 |
| Working Capital Days | 86.70 | 899.46 | 1,110.21 | 1,405.25 | 2,007.50 | 775.62 | 1,425.24 | 6,935.00 | 967.25 | 150.21 | 27.65 | -6,241.50 |
| ROCE % | 14.88% | 2.38% | 0.86% | 0.71% | 0.14% | 1.28% | 0.70% | 0.41% | 2.48% | 8.86% | 1.11% | 0.13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.00 | 0.01 | 0.07 | 0.02 | 0.00 |
| Diluted EPS (Rs.) | 0.00 | 0.01 | 0.07 | 0.02 | 0.00 |
| Cash EPS (Rs.) | 0.00 | 0.01 | 0.07 | 0.01 | 0.00 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.14 | 1.15 | 1.13 | 1.06 | 1.04 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.14 | 1.15 | 1.13 | 1.06 | 1.04 |
| Revenue From Operations / Share (Rs.) | 0.01 | 0.09 | 0.37 | 0.02 | 0.01 |
| PBDIT / Share (Rs.) | 0.00 | 0.01 | 0.10 | 0.02 | 0.00 |
| PBIT / Share (Rs.) | 0.00 | 0.01 | 0.10 | 0.02 | 0.00 |
| PBT / Share (Rs.) | 0.00 | 0.01 | 0.10 | 0.02 | 0.00 |
| Net Profit / Share (Rs.) | 0.00 | 0.01 | 0.07 | 0.01 | 0.00 |
| NP After MI And SOA / Share (Rs.) | 0.00 | 0.01 | 0.07 | 0.01 | 0.00 |
| PBDIT Margin (%) | 11.36 | 13.93 | 27.32 | 97.58 | 53.63 |
| PBIT Margin (%) | 11.36 | 13.93 | 27.32 | 97.58 | 53.63 |
| PBT Margin (%) | 9.64 | 13.93 | 27.32 | 96.38 | 53.29 |
| Net Profit Margin (%) | 2.96 | 10.31 | 18.79 | 66.28 | 39.44 |
| NP After MI And SOA Margin (%) | 2.96 | 10.31 | 18.79 | 66.28 | 39.44 |
| Return on Networth / Equity (%) | 0.03 | 0.87 | 6.29 | 1.81 | 0.31 |
| Return on Capital Employeed (%) | 0.15 | 1.17 | 8.60 | 2.49 | 0.40 |
| Return On Assets (%) | 0.02 | 0.73 | 4.60 | 1.60 | 0.28 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.06 | 0.06 | 0.05 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.06 | 0.06 | 0.05 |
| Asset Turnover Ratio (%) | 0.01 | 0.06 | 0.27 | 0.02 | 0.00 |
| Current Ratio (X) | 0.76 | 1.50 | 1.45 | 2.17 | 3.87 |
| Quick Ratio (X) | 0.76 | 1.50 | 1.45 | 2.17 | 3.87 |
| Interest Coverage Ratio (X) | 6.61 | 0.00 | 0.00 | 80.92 | 159.13 |
| Interest Coverage Ratio (Post Tax) (X) | 2.72 | 0.00 | 0.00 | 55.96 | 118.02 |
| Enterprise Value (Cr.) | 16.79 | 22.78 | 49.91 | 58.69 | 22.69 |
| EV / Net Operating Revenue (X) | 160.38 | 34.35 | 19.17 | 294.91 | 394.58 |
| EV / EBITDA (X) | 1411.06 | 246.49 | 70.16 | 302.20 | 735.67 |
| MarketCap / Net Operating Revenue (X) | 160.40 | 35.26 | 18.98 | 292.45 | 387.45 |
| Price / BV (X) | 2.14 | 2.98 | 6.36 | 7.99 | 3.12 |
| Price / Net Operating Revenue (X) | 161.18 | 35.26 | 18.99 | 292.76 | 391.57 |
| EarningsYield | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
After reviewing the key financial ratios for Croissance Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.14. It has decreased from 1.15 (Mar 24) to 1.14, marking a decrease of 0.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.14. It has decreased from 1.15 (Mar 24) to 1.14, marking a decrease of 0.01.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.01. It has decreased from 0.09 (Mar 24) to 0.01, marking a decrease of 0.08.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For PBDIT Margin (%), as of Mar 25, the value is 11.36. This value is within the healthy range. It has decreased from 13.93 (Mar 24) to 11.36, marking a decrease of 2.57.
- For PBIT Margin (%), as of Mar 25, the value is 11.36. This value is within the healthy range. It has decreased from 13.93 (Mar 24) to 11.36, marking a decrease of 2.57.
- For PBT Margin (%), as of Mar 25, the value is 9.64. This value is below the healthy minimum of 10. It has decreased from 13.93 (Mar 24) to 9.64, marking a decrease of 4.29.
- For Net Profit Margin (%), as of Mar 25, the value is 2.96. This value is below the healthy minimum of 5. It has decreased from 10.31 (Mar 24) to 2.96, marking a decrease of 7.35.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.96. This value is below the healthy minimum of 8. It has decreased from 10.31 (Mar 24) to 2.96, marking a decrease of 7.35.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 15. It has decreased from 0.87 (Mar 24) to 0.03, marking a decrease of 0.84.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 10. It has decreased from 1.17 (Mar 24) to 0.15, marking a decrease of 1.02.
- For Return On Assets (%), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.73 (Mar 24) to 0.02, marking a decrease of 0.71.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. It has decreased from 0.06 (Mar 24) to 0.01, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1.5. It has decreased from 1.50 (Mar 24) to 0.76, marking a decrease of 0.74.
- For Quick Ratio (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has decreased from 1.50 (Mar 24) to 0.76, marking a decrease of 0.74.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.61. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 6.61, marking an increase of 6.61.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.72. This value is below the healthy minimum of 3. It has increased from 0.00 (Mar 24) to 2.72, marking an increase of 2.72.
- For Enterprise Value (Cr.), as of Mar 25, the value is 16.79. It has decreased from 22.78 (Mar 24) to 16.79, marking a decrease of 5.99.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 160.38. This value exceeds the healthy maximum of 3. It has increased from 34.35 (Mar 24) to 160.38, marking an increase of 126.03.
- For EV / EBITDA (X), as of Mar 25, the value is 1,411.06. This value exceeds the healthy maximum of 15. It has increased from 246.49 (Mar 24) to 1,411.06, marking an increase of 1,164.57.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 160.40. This value exceeds the healthy maximum of 3. It has increased from 35.26 (Mar 24) to 160.40, marking an increase of 125.14.
- For Price / BV (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has decreased from 2.98 (Mar 24) to 2.14, marking a decrease of 0.84.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 161.18. This value exceeds the healthy maximum of 3. It has increased from 35.26 (Mar 24) to 161.18, marking an increase of 125.92.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Croissance Ltd:
- Net Profit Margin: 2.96%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.15% (Industry Average ROCE: 16.34%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.03% (Industry Average ROE: 21.32%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.72
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.76
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 48.9 (Industry average Stock P/E: 40.17)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.96%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Construction, Contracting & Engineering | 306, 1st Floor, 17th Cross, Bengaluru Karnataka 560032 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sravan Prabhakar Veledandi | Managing Director |
| Mr. Amaresh Rao Gaikwad | Whole Time Director |
| Mr. Hriday Bahri | Non Executive Director |
| Mr. Hemant Bahri | Director |
| Ms. Sowmya Ranganath | Independent Director |
| Ms. Shivani Marda | Addnl.Independent Director |
FAQ
What is the intrinsic value of Croissance Ltd?
Croissance Ltd's intrinsic value (as of 13 February 2026) is ₹0.66 which is 80.30% lower the current market price of ₹3.35, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹23.0 Cr. market cap, FY2025-2026 high/low of ₹4.32/2.21, reserves of ₹1.02 Cr, and liabilities of ₹15.24 Cr.
What is the Market Cap of Croissance Ltd?
The Market Cap of Croissance Ltd is 23.0 Cr..
What is the current Stock Price of Croissance Ltd as on 13 February 2026?
The current stock price of Croissance Ltd as on 13 February 2026 is ₹3.35.
What is the High / Low of Croissance Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Croissance Ltd stocks is ₹4.32/2.21.
What is the Stock P/E of Croissance Ltd?
The Stock P/E of Croissance Ltd is 48.9.
What is the Book Value of Croissance Ltd?
The Book Value of Croissance Ltd is 0.11.
What is the Dividend Yield of Croissance Ltd?
The Dividend Yield of Croissance Ltd is 0.00 %.
What is the ROCE of Croissance Ltd?
The ROCE of Croissance Ltd is 0.13 %.
What is the ROE of Croissance Ltd?
The ROE of Croissance Ltd is 0.00 %.
What is the Face Value of Croissance Ltd?
The Face Value of Croissance Ltd is 1.00.